GnRH Analog Therapy
Natural Testosterone & LH Support
Gonadorelin is a synthetic gonadotropin-releasing hormone (GnRH) analog that naturally stimulates the pituitary gland to produce luteinizing hormone (LH) and follicle-stimulating hormone (FSH), supporting endogenous testosterone production, reproductive health, and hormonal balance through physiological pathways.
5mg
Per Vial
SC/IM
Administration
GnRH
Analog Type
22+
BHRC Locations
Available Option
A synthetic gonadotropin-releasing hormone analog that stimulates natural LH and FSH production, promoting endogenous testosterone synthesis, fertility optimization, and reproductive hormone balance.
Gonadorelin 5mg per vial
Ideal For
Individuals seeking to restore natural testosterone production through the hypothalamic-pituitary-gonadal axis, support fertility and reproductive health, maintain testicular function during therapy, or optimize hormonal balance using physiological pathways.
The Science
Gonadorelin is a synthetic decapeptide analog of naturally occurring gonadotropin-releasing hormone (GnRH), also known as luteinizing hormone-releasing hormone (LHRH). It works by binding to GnRH receptors in the anterior pituitary gland, triggering the pulsatile release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH)—the key regulators of gonadal function and sex hormone production.
Unlike exogenous testosterone replacement, gonadorelin supports the body's natural hormonal cascade, stimulating endogenous testosterone synthesis in the testes while preserving testicular size and function. This makes it particularly valuable for individuals seeking to maintain fertility during hormone optimization, restore suppressed HPG axis function, or support reproductive health through physiological mechanisms.
At BHRC, our physicians utilize gonadorelin as part of comprehensive hormone replacement protocols, fertility preservation strategies, and testosterone optimization programs. Medical supervision ensures proper pulsatile dosing schedules, monitoring of hormone levels, and integration with broader treatment plans tailored to individual patient needs and therapeutic goals.
Book a Consultation
How It Works
Gonadorelin activates the hypothalamic-pituitary-gonadal axis through GnRH receptor binding, initiating a natural hormonal cascade that restores endogenous testosterone production and reproductive function.
Binds to GnRH receptors in the pituitary gland, stimulating pulsatile secretion of luteinizing hormone (LH)—the primary signal for Leydig cell activation and testosterone synthesis in the testes.
Triggers follicle-stimulating hormone (FSH) release, supporting spermatogenesis and testicular function—critical for maintaining fertility and reproductive capacity during hormone therapy.
Maintains endogenous testosterone production and testicular size by signaling the gonads—studied for supporting testicular size and fertility potential during optimization protocols.
Clinical Benefits
Stimulates endogenous testosterone production through the body's natural HPG axis—maintaining physiological hormone levels without suppressing testicular function or fertility.
Supports spermatogenesis and reproductive function by maintaining FSH and LH signaling—essential for men seeking to preserve fertility during testosterone therapy or hormone optimization.
May help maintain testicular size by stimulating LH-driven Leydig cell activity—addressing a common concern with traditional testosterone replacement therapy.
May support hypothalamic-pituitary-gonadal function after exogenous hormone use—helping normalize endogenous production and prepare for post-cycle recovery.
Optimizes the natural balance of LH, FSH, and testosterone through physiological signaling pathways—supporting comprehensive endocrine health and metabolic wellness.
Flexible dosing schedules tailored to individual hormone levels, treatment goals, and clinical response—enabling precision approaches to testosterone optimization and reproductive health.
Your Journey
Meet with a BHRC physician to discuss testosterone goals, fertility preservation needs, or HPG axis restoration and determine treatment candidacy.
Complete comprehensive hormone panel including total testosterone, LH, FSH, and other biomarkers to establish baseline function and optimize protocol.
Receive your personalized gonadorelin protocol with pulsatile dosing schedule, administration guidance, and integration with existing hormone therapy.
Regular follow-ups with hormone testing, testicular assessment, and protocol adjustments to optimize testosterone production and reproductive outcomes.
Safety & Candidacy
At BHRC, patient safety is paramount. Gonadorelin is administered only after thorough medical evaluation, comprehensive hormone testing, and confirmation of treatment candidacy by our licensed providers.
22+
BHRC locations providing comprehensive hormone optimization and reproductive health services
Physician
Supervised treatment protocols with ongoing hormone monitoring and clinical assessment
Quality
Verified sourcing and pharmaceutical-grade peptide standards with rigorous purity testing
At a glance
Your plan
The BHRC clinical team starts by separating two goals that often get blurred: feeling and functioning better on testosterone, and keeping fertility or testicular size. Gonadorelin is only relevant to the second, and the plan is different if a pregnancy is wanted in the next year.
Morning total and free testosterone on two occasions, LH, FSH, estradiol, prolactin, a blood count with hematocrit, PSA where age-appropriate, and metabolic labs. If fertility matters, a semen analysis is ordered before starting, because it is the only test that tells you what is actually happening.
If you are on or starting testosterone and want to keep signalling active, the team compares gonadorelin with hCG, which acts directly on the testes, and, in men who are not yet on testosterone, with options that raise your own production such as enclomiphene. The choice depends on your labs, goals and how practical the injection schedule is for you.
If gonadorelin is chosen, it is prescribed from a licensed pharmacy with a schedule and timing instructions. Dosing is individual; we do not publish a standard schedule because frequency and timing are what make GnRH stimulate rather than suppress.
Follow-up labs check LH, FSH, testosterone, estradiol and hematocrit, and a repeat semen analysis if fertility is a goal. If LH and FSH are not responding, gonadorelin is stopped or replaced rather than continued on hope.
Timeline
Baseline hormones on two mornings, blood count, PSA if indicated, and a semen analysis for fertility-focused plans.
LH and FSH respond to GnRH within hours of a dose, so early labs mostly confirm the pituitary is responding. Injection-site redness or a mild headache are the usual side effects.
Follow-up labs alongside the testosterone check. The team looks at LH, FSH and estradiol trends rather than one value.
Sperm production takes roughly three months to cycle, so a repeat semen analysis is not meaningful much earlier.
Reviewed at each lab check. If the main goal changes, for example a pregnancy plan, the approach is revisited, often with a reproductive specialist.
Compare
| Option | Where it acts | FDA status | Notes |
|---|---|---|---|
| Gonadorelin (this page) | Pituitary, via GnRH receptors | Previously approved products discontinued; compounded here | Short-acting, so the injection schedule matters |
| hCG | Directly on the testes (LH-like) | FDA-approved products exist for specific uses | Long-established in fertility care; bypasses the pituitary |
| Enclomiphene | Blocks estrogen feedback to raise LH/FSH | Not an approved product; FDA lists it in 503A Category 1 (under evaluation) | For some men not yet on testosterone; oral |
| Kisspeptin | Upstream of GnRH in the brain | Not approved; Kisspeptin-10 is in 503A Category 2 | Research interest; see our Kisspeptin page |
Is it right for you?
Monitoring
Gonadorelin is monitored through labs, not feelings. LH and FSH show whether the pituitary is responding, testosterone and estradiol show the downstream effect, and the blood count tracks hematocrit, which testosterone therapy can raise. For men with fertility goals, a semen analysis at baseline and roughly three months later is the only meaningful test, because hormone levels can look fine while sperm production does not.
Timing is the technical point that makes gonadorelin different. The body releases GnRH in pulses; continuous exposure has the opposite effect and switches LH and FSH off, which is how long-acting GnRH agonists are used to suppress hormones in prostate cancer care. Compounded gonadorelin is short-acting, which is why the BHRC clinical team gives precise timing instructions and checks labs to confirm it is stimulating rather than suppressing.
Exogenous testosterone lowers LH and FSH and can reduce sperm production to very low levels, sometimes to zero. Professional guidance recommends that men who want fertility in the near future should not be on testosterone alone. Gonadorelin is one of several tools used to keep the axis active, but the best-studied pulsatile GnRH data come from men with congenital hypogonadotropic hypogonadism using infusion pumps, not from men on TRT using intermittent injections. The team explains that gap and chooses the option with the evidence that fits your situation.
Estradiol is watched closely. When the testes are kept active alongside testosterone therapy, more testosterone can be converted to estradiol, and some men notice water retention, breast tenderness or mood change. The answer is usually to look at the labs and adjust the overall plan rather than adding another medication reflexively. The team also checks that the testosterone dose itself is not higher than it needs to be.
If you decide to come off testosterone, the plan changes. Stopping TRT leaves a gap while your own production restarts, which can take weeks to months and sometimes longer after years of use. The BHRC clinical team plans that transition with labs at set intervals, and in men with fertility goals coordinates with a reproductive specialist. Gonadorelin may or may not be part of that plan; it is not a guaranteed restart switch.
Side effects are usually mild: redness at the injection site, headache, flushing or nausea, and they are the first thing reviewed at the early follow-up. Hypersensitivity reactions have been described with GnRH products and mean stopping and calling. Breast tenderness or mood change can reflect estradiol shifts and are checked against labs.
Supply and preparation are part of monitoring too. Because gonadorelin is short-acting and sensitive to handling, the team relies on a licensed pharmacy's labelled concentration and storage instructions, and asks you to report any change in how a new vial looks or behaves. If labs suddenly change after a refill, the vial is one of the first things checked.
Every plan ends with a written summary of the labs and decisions, useful if you later see a fertility specialist.
Dosing, reconstitution and cycling detail is covered in our Gonadorelin dosage guide. Your own plan is set by your provider at the consultation.
Regulatory status
Gonadorelin is the active ingredient of two products FDA approved in the past, Factrel (gonadorelin hydrochloride) and Lutrepulse (gonadorelin acetate); both are listed as discontinued in Drugs@FDA. No gonadorelin product is currently marketed as FDA-approved for use with testosterone therapy or for male fertility. At BHRC it is prescribed as a compounded preparation from a licensed pharmacy, which is not FDA-approved, and only after a provider consultation, baseline labs and documented informed consent. Prepared by the BHRC team from FDA and PubMed sources.
Before you book
Testosterone therapy tells the brain to stop sending LH and FSH, so the testes make less of their own testosterone and less sperm, and often shrink. Gonadorelin is a GnRH signal meant to keep the pituitary sending LH and FSH while you are on testosterone. Whether it achieves that is checked with labs.
Keeping LH and FSH signalling active may help maintain testicular volume on testosterone, but responses vary and the evidence in men on TRT is limited. The clinical team tracks it with labs and examination rather than promising a size outcome.
Sometimes, but it is less common. In men not on testosterone whose own axis is working, adding a GnRH signal rarely makes sense, and options such as enclomiphene or simply addressing sleep, weight and alcohol are usually discussed first. The team decides from your labs.
Yes. It is a ten-amino-acid peptide identical in sequence to natural GnRH, also called LHRH. That is different from the long-acting GnRH agonists used in prostate cancer care, which are modified to last much longer and, because they act continuously, suppress the axis instead of stimulating it.
Neither is better for everyone. hCG acts directly on the testes and has a long track record in fertility care; gonadorelin acts one step higher, at the pituitary, and is short-acting. The BHRC team chooses based on your labs, goals, injection preferences and how you respond.
Recovery after testosterone or anabolic steroid use is a medical process that needs labs, a semen analysis and often a reproductive specialist. Gonadorelin may be one part of a plan, but no single peptide guarantees recovery, and the team will refer if a pregnancy is the goal.
Your amount, frequency and timing are set by the clinical team and adjusted to your labs. We do not publish a schedule because the pattern of dosing is what determines whether GnRH stimulates or suppresses the axis.
Gonadorelin was approved in the past as Factrel and Lutrepulse, and both products are now listed as discontinued in Drugs@FDA. No gonadorelin product is currently marketed as FDA-approved for use with testosterone therapy. What BHRC prescribes is a compounded preparation, which is not FDA-approved.
Cost depends on the consultation, the labs and semen analysis you need, the number of vials, and how often follow-up labs are drawn. If gonadorelin is part of a testosterone plan, it is quoted together. Your BHRC centre provides an itemised quote; prices are not on this page.
Book a hormone consultation. Bring any previous testosterone labs and tell the team whether fertility is a goal, because that changes which tests are ordered and which option is chosen. Our testosterone therapy guide explains candidacy and monitoring in more depth.
Selected research
The literature below is peer-reviewed background on Gonadorelin and the mechanisms discussed on this page, so you can read the primary sources yourself. It is not evidence of any particular outcome at BHRC, and some of it is preclinical work in animals or cells. Your provider will discuss what the evidence does and does not support for your situation.
Related peptide therapies
Peptide therapy
Growth Hormone Secretagogue • Healthy Aging Support
Common Questions
Gonadorelin is a synthetic analog of gonadotropin-releasing hormone (GnRH) that stimulates the pituitary gland to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This triggers natural testosterone production in the testes while maintaining testicular function and fertility—offering a physiological alternative to direct testosterone replacement.
Gonadorelin is administered via subcutaneous or intramuscular injection, typically using a pulsatile dosing protocol to mimic natural GnRH secretion patterns. Your BHRC physician will provide detailed injection training, specific dosing schedules (often multiple times per week), and monitoring guidelines based on your hormone levels and treatment goals.
Gonadorelin supports natural testosterone production through the HPG axis, maintains testicular size and function, preserves fertility and spermatogenesis, may help maintain testicular size during hormone therapy, and is studied for supporting endogenous hormone production. It offers a more physiological approach compared to exogenous testosterone while supporting comprehensive reproductive health.
Ideal candidates include men seeking to preserve fertility while optimizing testosterone, individuals on testosterone replacement therapy wanting to maintain testicular function, those recovering from suppressed HPG axis function, or anyone preferring natural testosterone stimulation over direct replacement. A BHRC physician will evaluate your hormone levels, fertility goals, and medical history to determine appropriateness.
Gonadorelin is generally well-tolerated when administered under medical supervision. Possible side effects may include mild injection site reactions, headache, nausea, or transient hormonal fluctuations during initial treatment. Continuous (non-pulsatile) administration can paradoxically suppress the HPG axis, which is why proper pulsatile dosing protocols are essential. Your BHRC physician will discuss all potential risks and monitoring requirements during consultation.
Response timelines vary based on individual physiology and baseline hormone status. LH and FSH levels typically increase within hours to days of initial dosing (measurable through blood testing), while improvements in testosterone production, testicular size, and fertility parameters may take several weeks to months. Your physician will establish realistic expectations and monitoring schedules to track progress and optimize your protocol.
Yes, gonadorelin can be integrated into testosterone replacement protocols to maintain testicular function, support fertility, and help maintain testicular size. It's commonly used alongside or as an adjunct to TRT for men who want comprehensive hormone optimization while preserving reproductive capacity. Your BHRC physician will coordinate dosing schedules and monitoring to optimize the synergy between treatments.
Get Started
Schedule a consultation with our medical team to learn if Gonadorelin peptide therapy is right for your testosterone optimization and reproductive health journey.
"*" indicates required fields
Or call us directly: +1 213-325-3373
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Gonadorelin is a peptide hormone analog not FDA-approved for testosterone optimization or fertility preservation. Individual results may vary. A consultation with our medical team, comprehensive hormone testing, and ongoing clinical monitoring are required to determine if this therapy is appropriate for you. Gonadorelin should be used only under qualified medical supervision as part of a comprehensive hormone optimization protocol.
